|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-8-3
|
|
pubmed:abstractText |
This study used tumour specimens from a clinical trial on intermittent androgen suppression (IAS) to study the effects of castration on tissue morphology, cell proliferation, apoptosis, and the expression of androgen receptor (AR).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Androgens,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Goserelin,
http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Testosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0302-2838
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
European Association of Urology
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
725-32
|
|
pubmed:meshHeading |
pubmed-meshheading:17141945-Androgen Antagonists,
pubmed-meshheading:17141945-Androgens,
pubmed-meshheading:17141945-Antineoplastic Agents, Hormonal,
pubmed-meshheading:17141945-Apoptosis,
pubmed-meshheading:17141945-Biopsy, Needle,
pubmed-meshheading:17141945-Caspase 3,
pubmed-meshheading:17141945-Cell Proliferation,
pubmed-meshheading:17141945-Disease Progression,
pubmed-meshheading:17141945-Dose-Response Relationship, Drug,
pubmed-meshheading:17141945-Follow-Up Studies,
pubmed-meshheading:17141945-Goserelin,
pubmed-meshheading:17141945-Humans,
pubmed-meshheading:17141945-Immunohistochemistry,
pubmed-meshheading:17141945-Ki-67 Antigen,
pubmed-meshheading:17141945-Male,
pubmed-meshheading:17141945-Neoplasm Staging,
pubmed-meshheading:17141945-Prostate-Specific Antigen,
pubmed-meshheading:17141945-Prostatic Neoplasms,
pubmed-meshheading:17141945-Testosterone,
pubmed-meshheading:17141945-Treatment Outcome,
pubmed-meshheading:17141945-Tumor Markers, Biological
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Cellular changes in prostate cancer cells induced by intermittent androgen suppression.
|
|
pubmed:affiliation |
Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
